Velocity Clinical Research has expanded its European senior executive team. Évelyne Newton joins as Vice President of Business Development, Sandra Stark as Vice President of European Operations and Maria Lehretz is the new Medical Director.
MMS Holdings announced the appointment of Chris Schoonmaker as Chief Operating Officer and Ashu Tandon as Chief Commercial Officer.
Sunitha Mathew, MS, has joined Westat's leadership team as its new Clinical Research Practice Director.
Clinical ink announced that healthcare industry veteran Jonathan Goldman MD has joined the company as Chief Executive Officer.
Vakzine Projekt Management GmbH announced the successful completion of a clinical client project with AntiBKV, an antibody targeting BK polyomavirus infection in renal transplant patients, for Memo Therapeutics AG, Switzerland.
Spaulding Clinical announced early results for a clinical trial as a part of the FDA’s proactive effort to address the opioid crisis and reduce opioid overdoses and deaths.
Verisense Health, Inc. announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff.
Medidata announced it was positioned as a Leader in the IDC MarketScape “Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment (doc #US48061722).”
OCT Clinical announced they have successfully completed the enrollment of 3,000 patients in a COVID-19 vaccine study.
Almac Group has won six CDMO Leadership Awards for 2023: Excellence in Capabilities (Small Pharma), Compatibility (Overall and Small Pharma), Expertise (Overall and Small Pharma), Quality (Overall and Small Pharma), Reliability (Overall and Small Pharma), and Service (Small Pharma).
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.